Early asthma drug trial halted after testing in small group
NCT ID NCT06592768
Summary
This was an early, small study to see if a single dose of an experimental drug called briquilimab could help control allergic asthma. It tested 17 adults with mild-to-moderate asthma, comparing the drug to a placebo (dummy treatment) to see if it reduced lung tightening caused by an allergen challenge. The main goals were to check the drug's safety and its effect on a delayed allergic reaction in the airways.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
McMaster University
Hamilton, Ontario, L8N 3Z5, Canada
-
University of Alberta
Edmonton, Alberta, T6G 2R3, Canada
-
University of British Columbia
Vancouver, British Columbia, V6T 1Z4, Canada
-
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
-
University of Laval
Québec, Quebec, G1V 0A6, Canada
-
University of Saskatchewan
Saskatoon, Saskatchewan, S7N 5A2, Canada
Conditions
Explore the condition pages connected to this study.